Literature DB >> 2458518

Home intravenous immunoglobulin therapy for patients with primary hypogammaglobulinaemia.

A Ryan, B J Thomson, A D Webster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2458518     DOI： 10.1016/s0140-6736(88)92439-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  The life situations of patients with primary antibody deficiency untreated or treated with subcutaneous gammaglobulin infusions.

Authors:  A Gardulf; H Björvell; R Gustafson; L Hammarström; C I Smith
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

2.  Management of primary antibody deficiency by consultant immunologists in the United Kingdom: a paradigm for other rare diseases.

Authors:  G P Spickett; T Askew; H M Chapel
Journal:  Qual Health Care       Date:  1995-12

Review 3.  Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes.

Authors:  S A Schwartz
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

4.  Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study.

Authors:  Eric Hachulla; Gwendal Le Masson; Guilhem Solé; Mohamed Hamidou; Claude Desnuelle; Jean-Philippe Azulay; Gérard Besson; Laure Swiader; Sébastien Abad; Jean-Christophe Antoine; Françoise Bouhour; Alain Créange; Marike Grenouillet; Laurent Magy; Sébastien Marcel; Jean-Michel Paquet; François Rouhart; François Ziegler; Stéphane Mathis; Marc Gauthier-Darnis; Sophie Puget
Journal:  Biomed Res Int       Date:  2018-03-15       Impact factor: 3.411

5.  Developing a Model of Care for Home Infusions of Natalizumab for People With Multiple Sclerosis.

Authors:  Timothy J Schultz; Anne Thomas; Paul Georgiou; Lynette Cusack; Mahasen Juaton; Lorraine Simon; Kerisha Naidoo; Kevin Webb; Jonathan Karnon; Janakan Ravindran
Journal:  J Infus Nurs       Date:  2019 Nov/Dec

6.  Home versus hospital immunoglobulin treatment for autoimmune neuropathies: A cost minimization analysis.

Authors:  Gwendal Le Masson; Guilhem Solé; Claude Desnuelle; Emilien Delmont; Marc Gauthier-Darnis; Sophie Puget; Isabelle Durand-Zaleski
Journal:  Brain Behav       Date:  2018-01-26       Impact factor: 2.708
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.